Price History
Feb 9, 2026 — Aug 24, 2026Investment Snapshot
- Trading 83% below Graham Number ($18.93) — significant margin of safety
- Piotroski F-Score 4/9 — moderate financial health
- Strong ROE of 37.0% with 4,104.3% net margin
- Revenue growing at 1,319% annually
Hyperion DeFi, Inc. - Common Stock (HYPD) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $49 million . Key value metrics: P/E ratio 1.3, P/B ratio 0.48, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Hyperion DeFi, Inc. - Common Stock — Fundamental Analysis Summary
Hyperion DeFi, Inc. - Common Stock (HYPD) is trading 83% below its Graham Number of $18.93 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 1.3x.
On financial health, HYPD shows a moderate Piotroski F-Score of 4/9, and strong return on equity of 37.0% (sector average: -20.1%), and minimal leverage with a debt-to-equity ratio of 0.17.
StockPik's composite Value Score for HYPD is 95/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
HYPD reports a high gross margin of 76.5% (sector average: 37.4%) and a strong operating margin of 3,896.3%.
HYPD shows revenue growing at 1,319% year-over-year, with earnings growing at 9%.